Insider Transactions in Q3 2025 at Phio Pharmaceuticals Corp. (PHIO)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2025
|
Curtis Lockshin Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,200
+46.61%
|
-
|
|
Sep 11
2025
|
David H Deming Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+50.0%
|
-
|
|
Sep 11
2025
|
Robert J Bitterman Chairman, Pres. & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+47.95%
|
-
|
|
Sep 11
2025
|
Robert J Bitterman Chairman, Pres. & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,111
-16.1%
|
$8,222
$2.32 P/Share
|
|
Sep 11
2025
|
Patricia A Bradford Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,800
+40.91%
|
-
|
|
Sep 11
2025
|
Lisa Cabott Carson VP, Finance and Administration |
BUY
Grant, award, or other acquisition
|
Direct |
47,000
+50.0%
|
-
|
|
Sep 11
2025
|
Robert L Ferrara Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+37.3%
|
-
|
|
Sep 11
2025
|
Jonathan E Freeman Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,700
+47.8%
|
-
|